COVID-19 Affects Glaucoma Patients

The COVID-19 pandemic has affected the lives of billions of people across the globe. For more than a year, the healthcare system has been severely bogged down, making it extremely difficult for individuals to receive eye disease treatments. COVID-19 affects glaucoma patients especially, and they are at risk of vision loss and blindness without access to essential treatments. A new survey shows that many people have not received a professional diagnosis for the condition; those with a diagnosis have struggled to attend medical appointments. Karen Osborn, Chief Executive Officer of Glaucoma UK, said:

"We know that many people will be doing their very best to maintain their eye health during the COVID-19 pandemic, however, the results of this survey highlight that more can be done to support people at this challenging time. Now more than ever, it is important that people with glaucoma keep their medical appointments, collect their prescriptions and use their eye drops as prescribed. Any disruption to care can lead to vision loss and permanent, irreversible blindness.

SDCB can help you or a loved one with vision loss or blindness. Please contact us to learn more about our programs and services.

"Survey Suggests That People Living With Glaucoma are Potentially at Increased Risk of Sight Loss and blindness due to COVID-19 Pandemic"